Aytu Biopharma, Inc.
AYTU
$2.21
$0.031.38%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
5/18/2026
-
ACCESS Newswire
5/16/2026
-
Simply Wall St
5/15/2026
-
The Cerbat Gem
5/14/2026
-
Seeking Alpha: Transcripts
5/14/2026
-
SeekingAlpha
5/13/2026
-
Zacks Investment Research
5/13/2026
-
Zacks Investment Research
5/13/2026
-
The Fly
5/13/2026
-
Seeking Alpha - Healthcare
5/13/2026
-
ACCESS Newswire
5/12/2026
-
Seeking Alpha - Healthcare
5/12/2026
-
Zacks Investment Research
5/12/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
5/6/2026
-
ACCESS Newswire
2/5/2026
-
Simply Wall St
2/4/2026
-
SeekingAlpha.com: All News
2/4/2026
-
SeekingAlpha
2/4/2026
-
Seeking Alpha: Transcripts
2/3/2026
-
Zacks Investment Research
2/3/2026
-
Nasdaq News: Markets
2/3/2026
-
Fool.com Headlines
2/3/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 3, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
720 437 6580
Address
Denver Corporate Center III
Suite 920 - 7900 East Union Avenue
Denver, CO 80237
Suite 920 - 7900 East Union Avenue
Denver, CO 80237
Country
Year Founded
--
Business Description
Sector
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment...
more